Tau‐targeting therapeutics: the next frontier in disease‐modifying treatments for Alzheimer’s disease

Abstract

The clinical development of tau‐targeting therapies for the treatment of Alzheimer’s disease (AD) represents a promising new frontier for the field.

The paper